Cataracts in Elderly Patients with Grade 1 Hypertension: Case Reports

Authors

  • Elizabeth Mega Sinaga Universitas Lampung
  • Winda Trijayanthi Utama

DOI:

https://doi.org/10.53089/medula.v17i1.1955

Keywords:

Hypertension, Cataracts, Elderly

Abstract

Cataract is one of the leading causes of blindness worldwide, including in Indonesia, particularly among the elderly population. Uncontrolled hypertension is believed to accelerate the development of cataract through mechanisms involving oxidative stress and microvascular dysfunction. This case is reported due to the frequent coexistence of hypertension and cataract in older adults; however, the relationship between systemic risk factor control and visual function preservation is often underemphasized. The aim of this report is to describe the clinical manifestations, risk factors, diagnostic approach, and management of a patient with hypertension and senile cataract. This case report is based on primary data obtained from medical history taking, physical examination, blood pressure measurement, and ophthalmological assessment. A 63-year-old male patient, Mr. H, was diagnosed with grade 1 hypertension and senile cataract, presenting with progressive right eye visual deterioration accompanied by a sensation of haze and glare. Clinical evaluation revealed a blood pressure of 145/93 mmHg, reduced visual acuity, lens opacity, and a positive shadow test, supporting the diagnosis. Management included administration of amlodipine 5 mg, lifestyle modification education such as a low-salt diet, increased physical activity, smoking cessation, and improved medication adherence. The patient was also referred to an ophthalmologist for further evaluation and consideration of phacoemulsification as definitive therapy. This case highlights that early recognition, blood pressure control, and appropriate management play an important role in slowing disease progression and preserving visual function.

Author Biographies

Elizabeth Mega Sinaga, Universitas Lampung

 

     

Winda Trijayanthi Utama

 

 

References

World Health Organization. Blindness and visual impairment [Internet]. Geneva: WHO; 2023 [cited 2026 Jun 24]. Available from:https://www.who.int/newsroom/fact-sheets/detail/blindness-and-visual-impairment

Flaxman SR, Bourne RRA, Resnikoff S, et al. Global causes of blindness and vision impairment in 2020 and projections to 2050.Lancet Glob Health. 2021;9(2):e144–e160.

Kementerian Kesehatan Republik Indonesia. Laporan Riskesdas 2018. Jakarta: Badan Litbangkes; 2019.

IAPB (International Agency for the Prevention of Blindness). Rapid assessment of avoidable blindness (RAAB) reports summary 2021–2023. London: IAPB; 2023.

Kementerian Kesehatan RI. Situasi gangguan penglihatan di Indonesia. Jakarta: Kemenkes RI; 2022.

Cheung CY, Ikram MK, Sabanayagam C, Wong TY. Retinal vascular caliber and hypertension-related eye disease: a systematic review. Hypertension. 2021;77(1):11–21.

Wang S, Wang JJ, Wong TY. Hypertension and risk of cataract: a meta-analysis of observational studies. Ophthalmology. 2021;128(6):936–945.

Zhang X, Liu Y, Li Y, et al. Association between hypertension and age-related cataract: a population-based study in Asia. BMC Ophthalmol. 2022;22:315.

Dinas Kesehatan Provinsi Lampung. Profil kesehatan Provinsi Lampung tahun 2023. Bandar Lampung: Dinkes Lampung; 2024.

Cai W, Liu H, et al. Oxidative stress and vascular dysfunction in hypertension-related ocular disease. Redox Biol. 2023;58:102517.

Wulandari R, Suryani D, et al. Management of hypertension in primary care settings in Indonesia. J Prim Care Community Health. 2024;15:1–9.

American Academy of Ophthalmology. Cataract in the adult eye preferred practice pattern. San Francisco: AAO; 2023.

Goh PP, et al. Oxidative stress and cataract formation: molecular mechanisms. Antioxidants. 2023;12(5):1120.

Williams B, Mancia G, et al. 2023 ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2023;44(38):3520–3623.

Gupta VB, Rajagopala M, et al. Phacoemulsification outcomes in age-related cataract. Clin Ophthalmol. 2022;16:345–353.

Harding JJ. Age-related cataract: oxidative mechanisms and pathogenesis. Eye (Lond). 2021;35(7):1857–1864.

World Health Organization. Hypertension fact sheet. Geneva: WHO; 2023. NCD Risk Factor Collaboration. Lifestyle modification and hypertension control. Lancet. 2023;401:123–134.

Kementerian Kesehatan Republik Indonesia. Pedoman pelayanan penyakit tidak menular di fasilitas kesehatan tingkat pertama. Jakarta: Kemenkes RI; 2022.

World Health Organization. Package of essential noncommunicable disease interventions (PEN) for primary care. Geneva: WHO; 2023.

Burton MJ, Ramke J, et al. The Lancet Global Health Commission on Global Eye Health: vision beyond 2020.

Lancet Glob Health. 2021;9(4):e489–e551.

Published

2026-06-24

How to Cite

Sinaga, E. M., & Utama, W. T. (2026). Cataracts in Elderly Patients with Grade 1 Hypertension: Case Reports. Medical Profession Journal of Lampung, 17(1), 88-93. https://doi.org/10.53089/medula.v17i1.1955

Issue

Section

Artikel

Similar Articles

You may also start an advanced similarity search for this article.